203 related articles for article (PubMed ID: 9336389)
1. Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays.
Ferrandi M; Manunta P; Balzan S; Hamlyn JM; Bianchi G; Ferrari P
Hypertension; 1997 Oct; 30(4):886-96. PubMed ID: 9336389
[TBL] [Abstract][Full Text] [Related]
2. Role of the ouabain-like factor and Na-K pump in rat and human genetic hypertension.
Ferrandi M; Manunta P; Rivera R; Bianchi G; Ferrari P
Clin Exp Hypertens; 1998; 20(5-6):629-39. PubMed ID: 9682919
[TBL] [Abstract][Full Text] [Related]
3. Ouabainlike factor in Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of a ouabain-like factor from Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
[TBL] [Abstract][Full Text] [Related]
5. Human adrenal cells in culture produce both ouabain-like and dihydroouabain-like factors.
el-Masri MA; Clark BJ; Qazzaz HM; Valdes R
Clin Chem; 2002 Oct; 48(10):1720-30. PubMed ID: 12324489
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
Meyer-Lehnert H; Bäcker A; Kramer HJ
Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
[TBL] [Abstract][Full Text] [Related]
7. Secretion of a lactone-hydrogenated ouabain-like effector of sodium, potassium-adenosine triphosphatase activity by adrenal cells.
Qazzaz HM; El-Masri MA; Valdes R
Endocrinology; 2000 Sep; 141(9):3200-9. PubMed ID: 10965891
[TBL] [Abstract][Full Text] [Related]
8. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
[TBL] [Abstract][Full Text] [Related]
9. Age-dependency and dietary influence on the hypothalamic ouabain-like factor in Milan hypertensive rats.
Ferrandi M; Minotti E; Florio M; Bianchi G; Ferrari P
J Hypertens; 1995 Dec; 13(12 Pt 2):1571-4. PubMed ID: 8903611
[TBL] [Abstract][Full Text] [Related]
10. Production of ouabain-like factor in normal and ischemic rat heart.
D'Urso G; Frascarelli S; Balzan S; Zucchi R; Montali U
J Cardiovasc Pharmacol; 2004 May; 43(5):657-62. PubMed ID: 15071352
[TBL] [Abstract][Full Text] [Related]
11. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
[TBL] [Abstract][Full Text] [Related]
12. An endogenous digitalis-like factor derived from the adrenal gland: studies of adrenal tissue from various sources.
Doris PA; Stocco DM
Endocrinology; 1989 Nov; 125(5):2573-9. PubMed ID: 2791999
[TBL] [Abstract][Full Text] [Related]
13. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous isolation of endogenous digoxin-like immunoreactive factor, ouabain-like factor, and deglycosylated congeners from mammalian tissues.
Qazzaz HM; Valdes R
Arch Biochem Biophys; 1996 Apr; 328(1):193-200. PubMed ID: 8638930
[TBL] [Abstract][Full Text] [Related]
15. Cellular mechanisms of action of a ouabain-like factor in vascular smooth-muscle cells.
Meyer-Lehnert H; Wanning C; Michel H; Bäcker A; Kramer HJ
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S16-9. PubMed ID: 7508017
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a digitalis-like substance in the hypothalamopituitary axis in rats: implications in the central cardiovascular regulation associated with an excess intake of sodium.
Takahashi H; Matsuzawa M; Okabayashi H; Suga K; Ikegaki I; Yoshimura M; Ijichi H; Okamura H; Murakami S; Ibata Y
Jpn Circ J; 1987 Oct; 51(10):1199-207. PubMed ID: 2828705
[TBL] [Abstract][Full Text] [Related]
17. Evidence of an endogenous ouabain-like immunoreactive compound with digitalis-like properties in the human.
Balzan S; Montali U; Ghione S
Ann N Y Acad Sci; 1997 Nov; 834():626-30. PubMed ID: 9405875
[No Abstract] [Full Text] [Related]
18. Circulating endogenous digitalis-like factor(s) (EDLF) in man is derived from the adrenals and its secretion is ACTH-dependent.
Sophocleous A; Elmatzoglou I; Souvatzoglou A
J Endocrinol Invest; 2003 Jul; 26(7):668-74. PubMed ID: 14594120
[TBL] [Abstract][Full Text] [Related]
19. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
20. Endogenous marinobufagenin-like factor in acute plasma volume expansion.
Fedorova OV; Doris PA; Bagrov AY
Clin Exp Hypertens; 1998; 20(5-6):581-91. PubMed ID: 9682914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]